← All trials
NCT00161759
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2002
- Primary completion
- —
- Completion date
- Jan 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- BaxaltaLead sponsor
- University of California, San DiegoOverall official - principal investigator
- Loyola UniversityOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- University of California, DavisOverall official - principal investigator
- University of California, IrvineOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- University of South AlabamaOverall official - principal investigator
- Wright State UniversityOverall official - principal investigator
- University of ArizonaOverall official - principal investigator
- Doctors Hospital, August, GAOverall official - principal investigator
- Yale UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.